Introduction
============

Insulin infusion in critically ill patients mandates frequent measurements of the blood glucose level \[[@B1]\]. Microdialysis is a well-established technology that offers the opportunity to sample blood analytes with high accuracy, without the need for drawing blood samples \[[@B2],[@B3]\]. We aimed to determine point and trend accuracy of microdialysis-based continuous glucose monitoring (CGM) (EIRUS®; Maquet Critical Care AB, Solna, Sweden).

Methods
=======

Patients with an expected stay in the ICU of \>48 hours needing an arterial catheter and a central venous catheter (CVC) were eligible. For a maximum of 3 days, during 8 hours per day, 125 μl blood was drawn from the arterial line every 15 minutes. Point accuracy was expressed using Clarke error grids, Bland-Altman plots and glucose prediction error analysis \[[@B4],[@B5]\]. Trend accuracy was expressed using continuous glucose error grid analysis \[[@B6]\].

Results
=======

Three-hundred and fifty-four paired samples were obtained from seven patients (66 (59 to 79) years old, APACHE II score 23 (20 to 28), 51 (19 to 77) samples per patient). Point accuracy: 91% of paired values were in zone A, with the remaining 9% of the values in zone B in the Clarke error grid. In the Bland-Altman, bias was 5.4 mg/dl with an upper limit of agreement of 32.5 mg/dl and a lower level of agreement of -21.8 mg/dl. Glucose prediction error analysis showed that 91% of the values ≥75 mg/dl within 20% of the values measured by the blood gas analyzer were within range. Trend accuracy: in the rate error grid of the continuous glucose error grid analysis, 96% of the paired values were in zone A, 3.7% were in zone B and 0.3% were in zone C.

Conclusion
==========

Point and trend accuracy of the tested microdialysis-based CGM are good in critically ill patients.
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